| Stage | ULTA | % of rev | SBH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.0B | 100.00% | $935M | 100.00% | ULTA ×3.25 |
| Gross profit | $1.2B | 39.10% | $490M | 52.41% | SBH +13.3pp |
| Operating income | $380M | 12.51% | $86M | 9.24% | ULTA +3.3pp |
| Pre-tax income | $376M | 12.38% | $73M | 7.77% | ULTA +4.6pp |
| Net income | $282M | 9.29% | $54M | 5.78% | ULTA +3.5pp |
| Stage | ULTA | SBH | Gap · A − B |
|---|---|---|---|
| Revenue | $3.0B100.00% | $935M100.00% | ULTA ×3.25 |
| Gross profit | 39.10%$1.2B | 52.41%$490M | SBH +13.3pp |
| Operating income | 12.51%$380M | 9.24%$86M | ULTA +3.3pp |
| Pre-tax income | 12.38%$376M | 7.77%$73M | ULTA +4.6pp |
| Net income |
| 9.29%$282M |
| 5.78%$54M |
| ULTA +3.5pp |
No disclosed counterparties: SBH.
None